7:30am Coffee Room Opens

8:15 am Chair’s Opening Remarks

Managing the Chain of Identity for Safer, More Reliable Patient-to-Patient Supply Chains

8:30 am Proposing Standardization to Create Industry-Wide Consensus with Minimal Complexity and Risk

• Karen Moniz Technical Director, ICCBBA

9:00 am Sharing Experience of Setting up and Scaling Chain of Identity Platforms, Highlighting Key Learnings and Future Improvements

• Beth Gardner Senior Director Patient Supply US, bluebird bio

9:30 am Creating a Paradigm Shift to Maximize Leukapheresis-Based Therapies Quality and Productivity: Full Switch From Fresh to Frozen Starting Material

• Ludwig Camusot Chief Corporate Development Officer, Cell Matter
• Mark W. Sawicki President & Chief Executive Officer, Cryoport Systems

10:00 am Case Study: Creating a Digital Ecosystem to Enable Real-Time Tracking, Scheduling and Follow-Up to Enhance Clinician, Patient, and Manufacturer Experience

• Stephen Chen COO, NKGen Biotech

10:30 am Morning refreshments & Speed Networking

Optimizing Cold Chain Logistics for Fast, Affordable, Temperature-Controlled Transport

11:00 am Developing Orchestration Platforms to Enable Industrial-Scale Maturity for Cell and Gene Delivery

• Tour Ala IT Lead for Cell & GTx Industrialization, Roche

11:30 am Cold Facts: A Discussion on Upstream Strategies to Ensure Downstream Cold Chain Scale Up Success

• David Lewandowski Director, Business Development, CGT, Azenta Life Sciences
• Brian Hawkins CTO, Pluristyx

12:00 pm Case Study: Designing a Cold Chain with Real-Time Feedback to Gather Tracking Data and Ensure Fast Response to Deviations

• Devin Blass VP Technical Operations, Talaris Therapeutics

12:30pm Lunch & Networking

Mastermind Session

1:30 pm Designing the Complementary GS1 and ISBT 128 Guidelines for Shipping Medical Products of Human Origin

• Karen Moniz Technical Director, ICCBBA

2:00 pm Next Steps to Advance the Field and Implement Standardized Practice for CGT Supply Chain and Logistics

• Christopher Baldwin Supply Chain Director, Cell Tx, GSK

2:30 pm Paving Future Directions for Industry Standards and Sharing Strategies to Integrate Standards Alongside Supply Chain Development

• Dawn Henke Senior Technical Program Manager, Standards Coordinating Body

3:00.pm Afternoon Refreshments

Preparing the Supply Chain & Logistics Ecosystem for Scale & Commercial Viability

3:30 pm Discussing Why Cell and Gene Companies Need to Invest in Supply Chain Organizational Setup Earlier Than Ever

• Nicole Rickard Head of Supply Chain, Cell & GTx, Vertex Pharmaceuticals
• Cindy McNab Supply Chain Director, Allogene Therapeutics

4:00 pm Panel Discussion: Outlining When to Invest in Supply Chain Organization, and Why Earlier is Better

• Nicole Rickard Head of Supply Chain, Cell & GTx, Vertex Pharmaceuticals
• Cindy McNab Supply Chain Director, Allogene Therapeutics
• Leanne Boytler Vice President, UK and Central European Logistics, Marken

4:30 pm Managing the Growing Momentum of CGT Clinical Development and Discussing the Barriers to Scale for Hospitals

• Albert Ribickas Supervisor, CGT Facility, Moffitt Cancer Center

5:00 pm Sharing Experience to Establish a Commercial Supply Chain and Logistics Organization as a Framework for Industry-Wide Harmonization and Scale-Readiness

• Paul Staid VP, CT Supply Chain, Bristol Myers Squibb

5:30 pm Chair’s Closing Remarks

5:45 pm Close of Summit